FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 19th, 2022 • Midatech Pharma PLC • Pharmaceutical preparations
THIS FIRST AMENDMENT to the Securities Purchase Agreement (this “Amendment”) is made and entered into as of December 16, 2022, by and between Midatech Pharma PLC, a public limited company organized under the laws of England and Wales (the “Company”), and a certain purchaser party to that certain Securities Purchase Agreement, dated as of December 13, 2022 (the “Purchaser”), by and between the Company and the Purchaser named therein (the “Purchase Agreement”). Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Purchase Agreement.
FIRST AMENDMENT TO ARRANGEMENT AGREEMENTArrangement Agreement • December 19th, 2022 • Midatech Pharma PLC • Pharmaceutical preparations
THIS FIRST AMENDMENT TO ARRANGEMENT AGREEMENT (this “Amendment”) is made and entered into as of December 18, 2022, by and between Midatech Pharma plc, a public limited company organized under the laws of England and Wales (“Buyer”) and Bioasis Technologies Inc., a corporation existing under the laws of British Columbia, Canada (the “Company”). Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in that certain Arrangement Agreement, dated as of December 13, 2022 (as my be amended, restated, supplemented or otherwise modified from time to time, the “Arrangement Agreement”), by and among Buyer and the Company.
